Adolescent Fitness Assessment Program (AFAP)
This study has been completed.
Sponsor:
University of Western Ontario, Canada
Information provided by (Responsible Party):
University of Western Ontario, Canada
ClinicalTrials.gov Identifier:
NCT01382121
First received: April 21, 2011
Last updated: June 25, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to implement a peer modeling intervention to improve self-efficacy and aerobic fitness in obese youth. A total of 40 obese (defined as Body Mass Index greater than the 95th percentile for age and gender) youth will participate in this study.
| Condition | Intervention | Phase |
|---|---|---|
|
Diabetes |
Behavioral: Peer Modeling Behavioral: Control |
Phase 0 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Increasing Self-efficacy and VO2 Max Scores in Obese Adolescents: a Peer Modeling Intervention |
Resource links provided by NLM:
Further study details as provided by University of Western Ontario, Canada:
Primary Outcome Measures:
- Physiological measure: Aerobic Fitness [ Time Frame: Baseline (day 1) and follow-up (day 7) ] [ Designated as safety issue: No ]Changes in aerobic fitness from baseline (day 1) to follow-up (day 7) will be evaluated by a trained exercise physiologist using a standardized, maximal incremental exercise protocol (Modified Bruce protocol) on a treadmill. Expired gases will be analyzed using a metabolic cart (Cosmed Quark B2 cardiopulmonary testing, Image Monitoring). Peak oxygen consumption (Peak VO2) will be determined by taking the highest values during a 15 second period and expressed in absolute (l/min) and relative (ml/kg/min) units with the latter unit used for subsequent analysis.
- Psychological: Self-Efficacy [ Time Frame: Baseline (day 1) and follow-up (day 7) ] [ Designated as safety issue: No ]Changes in self-efficacy from baseline (day 1) to follow-up (day 7) will be evaluated by an 18-item Self-Efficacy Scale (adapted from McAuley & Milhalko, 1998) to evaluate participants' confidence to successfully perform increasing intensities and durations of physical activity.
Secondary Outcome Measures:
- Changes in variability (standard deviation) [ Time Frame: Baseline (day 1) and follow-up (day 7) ] [ Designated as safety issue: No ]Changes in variability (standard deviation) in the aerobic fitness and self-efficacy data will be analyzed using statistical software.
| Enrollment: | 49 |
| Study Start Date: | September 2010 |
| Study Completion Date: | May 2012 |
| Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Peer modeling
Participants watch a video geared to increase confidence in ability to preform fitness test. Male participants will watch a video of a male adolescent completing the fitness test and talking about coping mechanisms used to preform to the best of his ability. Female participants will watch a video of a female adolescent completing the fitness test and talking about coping mechanisms used to preform to the best of her ability.
|
Behavioral: Peer Modeling
Participants watch a video of an adolescent completing the fitness test and explaining coping mechanisms to preform the test well.
Other Names:
|
|
Active Comparator: Control
Participants watch a video unrelated to the fitness test and self-efficacy. The video depicts healthy food and nutrition options.
|
Behavioral: Control
watching a video unrelated to the fitness test and self-efficacy
Other Names:
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 10 Years to 17 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Children and adolescents aged 10-17 years who are obese, defined as Body Mass Index greater than the 95th percentile for age and gender
Exclusion Criteria:
- Participants who smoke, are pregnant or have an illness or disease will be excluded from the study.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01382121
Locations
| Canada, Ontario | |
| Exercise and Health Psychology Laboratory | |
| London, Ontario, Canada, N6A 5B9 | |
Sponsors and Collaborators
University of Western Ontario, Canada
Investigators
| Principal Investigator: | Harry Prapavessis, PhD | University of Western Ontario, Canada |
More Information
Additional Information:
Publications:
| Responsible Party: | University of Western Ontario, Canada |
| ClinicalTrials.gov Identifier: | NCT01382121 History of Changes |
| Other Study ID Numbers: | PeakVO2 PM RCT |
| Study First Received: | April 21, 2011 |
| Last Updated: | June 25, 2012 |
| Health Authority: | Canada: Ethics Review Committee |
Keywords provided by University of Western Ontario, Canada:
|
Peer modeling Observational learning Obesity Adolescents |
Maximum ventilatory oxygen Aerobic fitness Health behaviour |
ClinicalTrials.gov processed this record on May 23, 2013